Loading
AHCC is a proprietary extract of shiitake mushroom mycelium taken to prevent and treat cancer. Early studies hint at fewer chemotherapy side effects and better outcomes after liver cancer surgery, but in a multicentre study in early prostate cancer it did not lower the blood marker it was meant to. It may weaken aromatase inhibitors.
Active hexose correlated compound is a proprietary extract from shiitake (Lentinus edodes) mycelia, rich in alpha-glucan oligosaccharides. Memorial Sloan Kettering's About Herbs summary describes immune effects in healthy adults (T-cell and dendritic-cell responses, better influenza vaccine antibody response) and preliminary findings that it may reduce recurrence after curative resection of hepatocellular carcinoma, improve nutrition during neoadjuvant therapy and reduce chemotherapy side effects. In an open-label multicentre study in early prostate cancer it did not achieve a 50 per cent or greater fall in prostate-specific antigen. MSK concludes further research is needed. Reported side effects are diarrhoea and mild itching. AHCC induces the liver enzyme CYP2D6, which could lower levels of drugs such as doxorubicin and ondansetron, and induces aromatase, which could reduce the activity of letrozole and anastrozole; the clinical importance of both is not known.
Low-molecular-weight alpha-glucans prime toll-like receptors in the gut lining and raise natural killer and T-cell activity in laboratory and small human studies.
Query for this technology: (TITLE:"AHCC" OR ABSTRACT:"AHCC" OR TITLE:"active hexose correlated compound" OR ABSTRACT:"active hexose correlated compound" OR TITLE:"Active hexose correlated compound" OR ABSTRACT:"Active hexose correlated compound") AND (cancer OR tumor OR tumour OR oncology OR carcinoma OR lymphoma OR leukemia OR leukaemia OR myeloma OR sarcoma OR melanoma OR glioma). Results are unfiltered search hits about AHCC (active hexose correlated compound), not a curated reading list.
Shares Maitake mushroom extracts, Dietary supplements during cancer treatment: interactions and harms, Evidence-based integrative oncology, Misinformation and unproven therapies and the tags complementary, supportive-care.
Shares MGN-3 (rice bran arabinoxylan, BioBran), Letrozole (and other aromatase inhibitors), Dietary supplements during cancer treatment: interactions and harms, Evidence-based integrative oncology and the tags complementary, supportive-care.
Shares Medicinal mushrooms: reishi, turkey tail, shiitake and others, Evidence-based integrative oncology, Misinformation and unproven therapies and the tags complementary, supportive-care.
Shares Medicinal mushrooms: reishi, turkey tail, shiitake and others, Evidence-based integrative oncology, Misinformation and unproven therapies and the tags complementary, supportive-care.
Shares Dietary supplements during cancer treatment: interactions and harms, Evidence-based integrative oncology, Misinformation and unproven therapies, Doxorubicin and the tags complementary, supportive-care.
Shares Anastrozole, Letrozole (and other aromatase inhibitors), Dietary supplements during cancer treatment: interactions and harms, Evidence-based integrative oncology and the tags complementary, supportive-care.
Shares Dietary supplements during cancer treatment: interactions and harms, Evidence-based integrative oncology, Misinformation and unproven therapies and the tags complementary, supportive-care.
Shares Dietary supplements during cancer treatment: interactions and harms, Evidence-based integrative oncology, Misinformation and unproven therapies, Doxorubicin and the tags complementary, supportive-care.
Every source this page cites, grouped by who published it. Grouping is read from the web address, not assigned by hand.
A source that has moved or gone is reported by the weekly link check. /audit/